[Development, prophylaxis and therapy of urinary TRACT infections following gynecological operations].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004599:Electric Stimulation Therapy; D005260:Female; D005831:Genital Diseases, Female / Q000601:surgery*; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects*; D007813:Laparotomy / Q000009:adverse effects; D008528:Mefenamic Acid / Q000627:therapeutic use; D009268:Nalidixic Acid / Q000627:therapeutic use; D009388:Neostigmine / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D010113:Oxyphenbutazone / Q000627:therapeutic use*; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010909:Pituitary Hormones, Posterior / Q000627:therapeutic use*; D011183:Postoperative Complications; D011704:Pyelonephritis / Q000209:etiology*; D014621:Vagina; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D010277:Parasympathomimetics; D010909:Pituitary Hormones, Posterior; D062367:ortho-Aminobenzoates; D008528:Mefenamic Acid; D009388:Neostigmine; D009268:Nalidixic Acid; D009582:Nitrofurantoin; D010113:Oxyphenbutazone
Entstehung, Prophylaxe und Therapie der Harnwegsinfektionen nach gynäkologischen Operationen.